Pár G - Search Results

1

[Non-alcoholic fatty liver disease and type 2 diabetes mellitus. I. Pathogenesis].

Pár A, Wittmann I, Pár G. Pár A, et al. Among authors: par g. Orv Hetil. 2022 May 22;163(21):815-825. doi: 10.1556/650.2022.32479. Print 2022 May 22. Orv Hetil. 2022. PMID: 35598211 Review. Hungarian.

2

The key-role of vagal nerve and adrenals in the cytoprotection and general gastric mucosal integrity.

Mózsik G, Karádi O, Király A, Debreceni A, Figler M, Nagy L, Pár A, Pár G, Süto G, Vincze A. Mózsik G, et al. Among authors: par g, par a. J Physiol Paris. 2001 Jan-Dec;95(1-6):229-37. doi: 10.1016/s0928-4257(01)00030-4. J Physiol Paris. 2001. PMID: 11595442

3

Decrease in CD3-negative-CD8dim(+) and Vdelta2/Vgamma9 TcR+ peripheral blood lymphocyte counts, low perforin expression and the impairment of natural killer cell activity is associated with chronic hepatitis C virus infection.

Pár G, Rukavina D, Podack ER, Horányi M, Szekeres-Barthó J, Hegedüs G, Paál M, Szereday L, Mózsik G, Pár A. Pár G, et al. Among authors: par a. J Hepatol. 2002 Oct;37(4):514-22. doi: 10.1016/s0168-8278(02)00218-0. J Hepatol. 2002. PMID: 12217606 Clinical Trial.

4

[Liver fibrosis: pathophysiology, diagnosis and treatment].

Pár A, Pár G. Pár A, et al. Among authors: par g. Orv Hetil. 2005 Jan 2;146(1):3-13. Orv Hetil. 2005. PMID: 15715367 Review. Hungarian.

5

[Safety of pegylated interferon in patients with hepatitis C virus induced cirrhosis].

Gasztonyi B, Pár G, Pár A, Hunyady B. Gasztonyi B, et al. Among authors: par g, par a. Orv Hetil. 2005 Nov 27;146(48):2431-4. Orv Hetil. 2005. PMID: 16408382 Clinical Trial. Hungarian.

6

Involvement of serum retinoids and Leiden mutation in patients with esophageal, gastric, liver, pancreatic, and colorectal cancers in Hungary.

Mózsik G, Rumi G, Dömötör A, Figler M, Gasztonyi B, Papp E, Pár A, Pár G, Belágyi J, Matus Z, Melegh B. Mózsik G, et al. Among authors: par g, par a. World J Gastroenterol. 2005 Dec 28;11(48):7646-50. doi: 10.3748/wjg.v11.i48.7646. World J Gastroenterol. 2005. PMID: 16437692 Free PMC article.

7

[Immunology of HCV infection: the causes of impaired cellular immune response and the effect of antiviral treatment].

Pár G, Berki T, Pálinkás L, Balogh P, Szereday L, Halász M, Szekeres-Barthó J, Miseta A, Hegedus G, Mózsik G, Hunyady B, Pár A. Pár G, et al. Among authors: par a. Orv Hetil. 2006 Apr 2;147(13):591-600. Orv Hetil. 2006. PMID: 16623441 Hungarian.

8

[The 43rd Annual Meeting of the European Association for the Study of the Liver (EASL), Milan, Italy, April 23-27, 2008].

Pár A, Pár G. Pár A, et al. Among authors: par g. Orv Hetil. 2008 Jul 13;149(28):1329-32. doi: 10.1556/OH.2008.28B. Orv Hetil. 2008. PMID: 18617461 Hungarian. No abstract available.

9

[Effects of supplementation with the antioxidant flavonoid, silymarin, in chronic hepatitis C patients treated with peg-interferon + ribavirin. A placebo-controlled double blind study].

Pár A, Roth E, Miseta A, Hegedüs G, Pár G, Hunyady B, Vincze A. Pár A, et al. Among authors: par g. Orv Hetil. 2009 Jan 11;150(2):73-9. doi: 10.1556/OH.2009.28517. Orv Hetil. 2009. PMID: 19103558 Clinical Trial. Hungarian.

10

Mannose-binding lectin deficiency confers risk for bacterial infections in a large Hungarian cohort of patients with liver cirrhosis.

Altorjay I, Vitalis Z, Tornai I, Palatka K, Kacska S, Farkas G, Udvardy M, Harsfalvi J, Dinya T, Orosz P, Lombay B Jr, Par G, Par A, Csak T, Osztovits J, Szalay F, Csepregi A, Lakatos PL, Papp M. Altorjay I, et al. Among authors: par g, par a. J Hepatol. 2010 Sep;53(3):484-91. doi: 10.1016/j.jhep.2010.03.028. Epub 2010 Jun 2. J Hepatol. 2010. PMID: 20605050

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

75 results

Search Page